2011 Era of Hope Highlights
Dr. James V. Alvarez
University of Pennsylvania
Pathways Regulating Tumor Recurrence
Dr. Oleg Andreev
University of Rhode Island
Targeted Delivery of Gold Nanoparticles to Breast Tumors
Dr. Ulus Atasoy
University of Missouri
Going Fishing with RNA Binding Proteins
Dr. Atasoy's Poster
Dr. Gautam Chaudhuri
Meharry Medical College
SLUG Regulation of Cyclin D1 in Breast Cancer Cells
Dr. Chaudhuri's Poster
Dr. Gayathri Devi
Duke University Medical Center
Targeted Strategy to Overcome Resistance to Immunotherapy
Dr. Devi's Poster
Dr. Craig Duvall
Vanderbilt University
Surface Functionalized Nanoparticles for Proximity Activated Targeting of Dual-Mode Therapy for Multidrug Resistant Breast Cancer
Dr. Chris A. Haiman
University of Southern California
A Genome-Wide Breast Cancer Scan in African Americans
Dr. W. Elaine Hardman and Dr. Philippe Georgel
Marshall University School of Medicine
Maternal Consumption of Omega-3 Reduces Breast Cancer in Offspring
Dr. Roger Harrison
University of Oklahoma
Novel Enzyme Prodrug Therapy for Breast Cancer
Dr. Harrison's Poster
Dr. Richard Paul Junghans
Roger Williams Medical Center/Boston University School of Medicine
Designer T Cell Gene Therapy to Eradicate Metastatic Breast Caner
Dr. Junghans' Poster
Dr. Meggan Keith
State University of New York at Albany
Modeling Impact of BRCA1 and BRCA2 Mutations in Mammary Epithelial Cells
Dr. David L. Kleinberg
New York University School of Medicine and Veterans Affairs Medical Center
Inhibition of IGF-1 for Breast Cancer Prevention and Treatment
Dr. Kleinberg's Poster
Dr. Fengshan Liu and Dr. Charlie D. Wilson
Delaware State University
Image-Based Biomarkers for Breast Cancer Risk
Dr. Liu and Dr. Wilson's Poster
Dr. Lisa Joy McCawley
Vanderbilt University Medical Center
A Breast Cancer Tissue Bioreactor
Dr. McCawley's Poster
Dr. Renata Pasqualini
MD Anderson Cancer Center
Ligand-Directed Targeted Molecular Imaging
Dr. Pasqualini's Poster
Dr. Andrea Patenaude
Dana-Farber Cancer Institute, Harvard Medical School
Cancer Worry and Risk Knowledge in 18-24-Year Old Daughters of BRCA1 and BRCA2 Mutation Carriers
Dr. Patenaude's Poster
Dr. Max S. Wicha
University of Michigan Comprehensive Cancer Center
Overcoming Resistance to Her-2 Targeted Therapies
Dr. Robert Wieder
UMDNJ-New Jersey Medical School/University Hospital Cancer Center
A Microfluidic Approach for Cancer Cell Surface Protein Analysis